Donor-specific effects played a large role in engraftment success and potentially GVHD risk in this study. Three patients developed acute GVHD; all received FMT from Donor 1 ... protective antibodies ...
The Fred Hutch trial illustrates this next phase in the development of donor-derived microbial ... be used to improve human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback